The evidence for Multiple Sclerosis (M.S) being a dietary problem is growing; can a low inflammation diet be part of the answer?
A while ago I reported about M.S. being a dietary problem and how one doctors journey led her to change how she eats after the traditional route failed to alleviate the condition. You can read the previous post here.
Apparently, the approach to treatment is moving toward the direction of dietary changes and dosing diet differently than trying to manage the condition naturally.
Check out this blog post regarding to a new approach to treatment of the condition.
Diet: Changing the recipe
Nature 540, S13″“S14 (01 December 2016) doi:10.1038/540S13a
Published online 30 November 2016
Ilana Katz Sand’s grocery shopping list for people with multiple sclerosis (MS) includes fish, whole grains, nuts, almond milk, blueberries and carrots. It excludes milk, cheese, meat, crisps and foods containing refined flour or sugar.
Katz Sand, a neurologist and MS specialist at the Mount Sinai Hospital in New York City, says she came up with this diet after scouring the literature for studies, often in animal models, that found a correlation between a given food, supplement or dietary restriction and positive outcomes in MS.
But rather than looking at a single ingredient, or providing patients with ready-made, standardized meals, Katz Sand wants to let patients buy their own ingredients and prepare their food at home. “œPeople are not mice,” she says. “œWe can’t put them in a cage and feed them exactly what we want to feed them.”
And that’s the problem. Hints have begun to emerge that dietary (and lifestyle) changes that reduce inflammation may help people to control their MS, but it is simply not possible to study diet in the same way as drugs. When researchers test a new drug, they divide people randomly into a treatment or a control group, blind all participants and investigators to that selection, and then provide a standardized amount of the drug or placebo for a set length of time. This highly regimented set-up, known as a double-blind, randomized, controlled trial, is the gold standard for drug research.